Abzena is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO), offering comprehensive services for biologics, bioconjugates, and antibody-drug conjugates (ADCs). Their expertise spans drug discovery, development, and GMP manufacturing, supporting the entire lifecycle of drug products from early discovery to commercialisation.

Key Products and Services

• Antibody discovery and development
• Bioconjugate and ADC design, development, and manufacturing
• Cell line development and process development
• Immunogenicity testing with EpiScreen® 2.0
• Complex chemistry, including payload and linker design
• GMP manufacturing for clinical and commercial stages

Abzena is committed to advancing complex biologics and helping clients deliver life-changing therapies to the market. Through integrated, high-quality services, they provide tailored solutions that accelerate drug development timelines.